DHG Pharmaceutical

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 18:00:00 2024-05-23 EDT			5-day change	1st Jan Change
117,400 ^VND	+1.12%		+1.56%	+12.88%

04-19	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung	CI

DHG Pharmaceutical JSC Announces Appointment of Pham Chi Truc as Finance Deputy General Director, Effective July 4, 2020

July 01, 2020 at 11:07 pm

DHG Pharmaceutical JSC announced appointment of Mr. Pham Chi Truc as Finance Deputy General Director, effective July 4, 2020.

Latest news about DHG Pharmaceutical

DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung	03-27	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	01-19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01-19	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	01-02	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20	CI
DHG Pharmaceutical Joint Stock Company Announces Change in Personnel	23-04-21	CI
DHG Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2022, Payable on May 12, 2023	23-04-21	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-19	CI
DHG Pharmaceutical Joint Stock Company Approves Executive Changes	22-12-04	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
DHG Pharmaceutical Joint Stock Company Announces Cash Dividend for the for 2021, Payable on April 15, 2022	22-03-24	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-01-19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-19	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-21	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-19	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-21	CI
DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Year 2020	20-07-03	CI

DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for DHG Pharmaceutical

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

117,400 VND

Average target price

116,593 VND

Spread / Average Target

-0.69%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DHG PHARMACEUTICAL	+12.88%	603M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B

Other Pharmaceuticals